Watson Pharmaceuticals (WPI) receives WPI) receives final approval from the FDA for a generic...
Watson Pharmaceuticals (WPI) receives final approval from the FDA for a generic version of Actos. began The company has already begun shipping the product. For the 12 months ending August 31, Actos and its generic equivalents had total U.S. sales of approximately $2.7B.
From other sites
at CNBC.com (Feb 18, 2015)
at CNBC.com (Feb 10, 2015)
at CNBC.com (Feb 5, 2015)
at CNBC.com (Jan 30, 2015)
at CNBC.com (Jan 26, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs